US Broker Ratings

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking a 16% Potential Upside and Strong Buy Ratings

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the health information services sector, continues to capture investor attention with its innovative cloud-based solutions tailored for the life sciences industry...

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 22.60% Upside Potential in Healthcare

Investors looking for opportunities in the healthcare sector should take a closer look at Fresenius Medical Care AG (FMS), a global leader in dialysis and renal healthcare services. With its..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Is an 8.35% Dividend Yield Worth the Risk?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare and pharmaceutical retail sector, presents an intriguing case for investors, particularly those with an appetite for high dividend yields...

Humana Inc. (HUM) Stock Analysis: Navigating Potential Amid Revenue Growth and Analyst Sentiment

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans industry, continues to be a focal point for investors seeking opportunities in the healthcare sector. With a market capitalization..

ICON plc (ICLR) Stock Analysis: A 26% Potential Upside Amidst Healthcare Innovation

Investors with an eye on the healthcare sector should take a closer look at ICON plc (NASDAQ: ICLR), a prominent player in the diagnostics and research industry. With its headquarters..

Summit Therapeutics Inc. (SMMT): Analyst Ratings and Potential Upside in Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a notable player within the biotechnology industry, specifically focusing on the development of innovative therapies aimed at addressing unmet medical needs. Based in..

argenx SE (ARGX) Stock Analysis: Biotechnology Powerhouse with 8.28% Upside Potential

argenx SE (NASDAQ: ARGX), a Netherlands-based biotechnology firm, has garnered significant attention in the healthcare sector, particularly for its innovative therapies targeting autoimmune diseases. With a market capitalization of $45.95..

DaVita Inc. (DVA) Investor Outlook: Assessing a Potential 11% Upside Amid Strong Cash Flow

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of $9.86 billion, DaVita stands..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Evaluating a 24.3% Upside in the Healthcare Giant

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, continues to capture investor attention with its promising growth potential and strategic positioning in the drug manufacturing industry...

Novo Nordisk A/S (NVO) Stock Analysis: 15.81% Potential Upside Fuels Investor Interest

Novo Nordisk A/S (NVO), a Danish healthcare giant, stands as a beacon of innovation and growth in the pharmaceutical industry. With a market capitalization of $250.23 billion, this titan in..

Baxter International Inc. (BAX) Stock Analysis: Exploring a Healthcare Giant with 18.76% Potential Upside

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently drawing investor attention with its attractive potential upside of 18.76%. With a market cap of $12.54..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating Healthcare’s Growth with Cautious Optimism

Smith & Nephew SNATS, Inc. (SNN), a prominent player in the healthcare sector, operates within the medical devices industry. Based in the United Kingdom, this stalwart company boasts a substantial..

GSK plc (GSK) Stock Analysis: Navigating a Complex Landscape with a Strong Dividend Yield

For individual investors seeking exposure to the healthcare sector, particularly in drug manufacturing, GSK plc (NYSE: GSK) presents a compelling profile. With a rich history dating back to 1715, this..

Incyte Corporation (INCY) Stock Analysis: Navigating Growth in the Biotech Sector

Incyte Corporation (NASDAQ: INCY) continues to make notable strides in the biotechnology sector, attracting investor interest with its promising therapeutics and a solid growth trajectory. As a leading biopharmaceutical company..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring an 18% Potential Upside and Strong Analyst Consensus

Elevance Health, Inc. (NYSE: ELV), a formidable player in the healthcare plans sector, has caught the attention of investors with its robust financial metrics and promising growth potential. With a..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a 14.83% Potential Upside in Healthcare

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is presenting a compelling opportunity for investors with a notable potential upside of 14.83%. With a market..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 9.96% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to attract investor interest with its promising portfolio and robust market presence. With a market capitalization of $152.7 billion,..

Agilent Technologies, Inc. (A): Investor Outlook with a 7.31% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a key player in the healthcare sector, specifically within the diagnostics and research industry, is catching the eye of investors with a notable potential upside..

UnitedHealth Group (UNH) Stock Analysis: Navigating a 4.66% Potential Upside Amid Healthcare Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector with a market cap of $285.64 billion, continues to capture investor interest with its robust business operations and solid..

Eli Lilly (LLY) Stock Analysis: Strong Buy Ratings and 22% Upside Potential Highlight Growth Opportunity

Eli Lilly and Company (NYSE: LLY) has long been a titan in the healthcare sector, specializing in the development and marketing of human pharmaceuticals globally. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds